Table 1.

Characteristics of the Patients with the Rheumatic diseases and asymptomatic hyperuricemia.

Age, years
(Mean±SD)
Male, %**Serum UA, μmol/l
(Mean±SD)
Normalization of UA during the follow-up, n (%)
RD, n=82256.7±14.540.27493.3±98.5242 (29.44) ##
RA, n=32964.2±12.13.74504.8±107.5#99 (30.09) ##
PsA, n= 14956.6±12.953.69531.5±94.9#32 (21.48) ##
SpA, n= 10745.6±15.1*33.43520.8±86.5#18 (16.82)##
SLE, n=13750.3±14.1*20.44451.6±91.457 (41.61)
SSc, n= 5761.0±12.422.81456.2±99.520 (35.09)
SD, n= 4362.0±10.716.28442.4±107.516 (37.21)
  • RD – rheumatic disease; RA –– rheumatoid arthritis; PsA –– psoriatic arthritis; SpA –– spondyloarthritis; SLE –– systemic lupus erythematosus; SSc –– systemic sclerosis; SD –– Sjogren’s disease; * –– p<0.001 for the differences with RD, RA, PsA, SSc, SD; ** –– p < 0.01 for all intergroup differences; # –– p < 0.01 for the differences with RD, RA, SSc, SD; ##–– p < 0.01 for the differences with RA, SSc, SD.